-
Bitcoin Miners Hive Digital, Hut 8, Bitfarms To Report Earnings As Future Of Crypto 'Has Never Been Brighter'
Tuesday, November 12, 2024 - 2:45pm | 678Read More...Bitcoin (CRYPTO: BTC) has soared to all-time highs following Donald Trump's election win, also lifting Bitcoin mining stocks on a wave of positive sentiment. Here's a look at what to watch as several Bitcoin miners are set to report earnings before Wednesday's opening bell. Hut 8 Corp.'s (NASDAQ:...
-
Bluebird Bio Price Target Bumped To $58 On Directional Improvements
Wednesday, November 1, 2017 - 2:54pm | 302Read More...In the biotechnology sector, Canter Fitzgerald analyst Elemer Piros increased his price target for bluebird bio Inc (NASDAQ: BLUE) from $39 to $58, but he maintains an Underweight rating. He increased the price target following the introduction of a multiple-myeloma model to his net present value...
-
What Wall Street Thinks Of F5's CEO Change
Thursday, April 23, 2015 - 11:58am | 692Read More...F5 Networks, Inc. (NASDAQ: FFIV) reported Q2 earnings Wednesday and beat expectations. F5 reported EPS of $1.59 on revenue of $472.14 million, while analysts expected F5 to post EPS of $1.50 on revenue of $471.14 million. The stock responded by spiking higher and recently traded at $122.94,...
-
Priceline Analyst Roundup
Friday, May 9, 2014 - 4:15pm | 301Read More...Shares of Priceline (NASDAQ: PCLN) fell 2.1 percent Thursday after the company disappointed investors with forward guidance. Revenue and income, however, were better than expected. Below is a summary of analyst commentary following the announcement. Jefferies - Reiterate Buy and $1,500 Price...
-
UPDATE: Cantor Fitzgerald Lowers PT on Ventrus Biosciences on 4Q Earnings Report
Tuesday, March 19, 2013 - 9:35am | 137Read More...Cantor Fitzgerald analyst Adeyemi Ogunkoya published a report on Ventrus Biosciences (NASDAQ: VTUS) that maintained its Buy rating and lowered the price target from $6 to $5. Cantor Fitzgerald reported that, “The lower-than-expected spending was associated with the closure of the VEN-309...
-
UPDATE: Cantor Fitzgerald Reiterates Synergy Pharmaceuticals at Buy on Late Breaker Announcement
Friday, March 15, 2013 - 1:32pm | 114Read More...In a report published by Cantor Fitzgerald, analyst Irina Rivkind reiterated a Buy rating and $13 price target on Synergy Pharmaceuticals (NASDAQ: SGYP). Cantor Fitzgerald reported that, “DDW Late Breaker announcement is an important catalyst for SGYP: Synergy announced that it would present full...
-
UPDATE: Cantor Fitzgerald Upgrades Intuitive Surgical to Buy on Attractive Risk/Reward Profile
Friday, March 1, 2013 - 10:33am | 158Read More...In a report published Friday, Cantor Fitzgerald Upgraded shares of Intuitive Surgical (NASDAQ: ISRG) and raises price target to $575 on attractive risk reward profile. Cantor Fitzgerald said that, “While we certainly understand investor concern over the words "FDA Probe," we see limited risk of...
-
UPDATE: Cantor Fitzgerald Raises PT on Priceline.com, Growth Stronger Than Expected
Wednesday, February 27, 2013 - 2:47pm | 90Read More...In a report published Wednesday, Cantor Fitzgerald reiterated Priceline.com (NASDAQ: PCLN) with a Buy rating and raised the price target from $750 to $800 on solid booking growth. Cantor Fitzgerald reported that, “Stronger-than-expected growth in international bookings and 1Q outlook demonstrate...
-
Ellington Financial Announces Pricing of Initial Public Offering
Friday, October 8, 2010 - 8:56am | 210Read More...Ellington Financial LLC (NYSE: EFC) today announced the pricing of its initial public offering of 4,500,000 common shares representing limited liability company interests at a price to the public of $22.50 per share. Ellington Financial LLC has also granted the underwriters a 30-day option to...
-
Cantor Fitzgerald Is Keen On GFIG And SIEB
Monday, September 28, 2009 - 1:37pm | 54Read More...Mike Khouw of Cantor Fitzgerald said for CNBC's Fast Money that an investor should closely watch GFI Group (NASDAQ: GFIG), and Siebert (NASDAQ: SIEB). Both stocks were up on Monday, CFI Group (CFIG) jumped more than 2%, while Siebert (SIEB) skyrocketed 10%.
